A recent study reported elevated levels of Th17 cell cytokines (IL-17A and IL-17F) in T cell non-inflamed triple-negative breast cancer; thus, IL-17 was proposed as a novel prognostic biomarker for this type of cancer [80]. The gene discussed is IL17A; the disease is triple-negative breast carcinoma.